查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1853619

菸鹼醯胺市場依用途、劑型、通路、最終用戶和性質分類－2025-2032年全球預測

Niacinamide Market by Application, Form, Distribution Channel, End User, Nature - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，菸鹼醯胺市場規模將成長至 10.9026 億美元，複合年成長率為 4.86%。

關鍵市場統計數據
基準年2024年 7.456億美元
預計年份：2025年 7.8266億美元
預測年份 2032 1,090,260,000 美元
複合年成長率（%） 4.86%

菸鹼醯胺的簡明策略方向，闡述其在營養、化妝品、飼料和治療產品生態系統中的多學科相關性。

菸鹼醯胺已從一種用途狹窄的成分發展成為一種多功能活性成分，其應用領域涵蓋營養、動物保健、化妝品和製藥等多個行業。作為維生素B3的重要形式，其功能多樣性——從支持皮膚屏障到在飼料和治療應用中發揮代謝作用——吸引了配方師、製造商和採購團隊的廣泛關注。本文將從當代市場需求促進因素和技術考量的角度，對菸鹼醯胺進行介紹，並將重點放在決策者需要了解的方面。

如今，產業相關人員面臨更複雜的局面，消費者訴求、監管審查、供應鏈韌性以及原料來源等因素都會同時影響產品策略。因此，產品經理和研發負責人必須兼顧產品的保存期限和配方穩定性與感官和功效預期。同時，採購和供應鏈專業人員必須應對可能影響原料來源、合成路線、供應和成本基礎的貿易摩擦。

本節透過重點闡述菸鹼醯胺的跨領域相關性如何需要製定綜合計劃，為後續的詳細分析奠定了基礎。它強調了將科學、監管合規和籌資策略置於商業計劃核心的重要性，以維護品牌信譽並滿足不斷變化的市場需求。

隨著消費者、監管和生產重點的變化，菸鹼醯胺的來源、配方和產品差異化策略發生了哪些變化？

菸鹼醯胺市場正因消費者期望的改變、配方創新和供應鏈重組而發生巨變。在消費者對潔淨標示和多功能活性成分需求不斷成長的推動下，各大品牌優先考慮成分透明度和可追溯性，而研發團隊則致力於開發能夠最佳化生物有效性和化妝品兼容性的遞送系統。這些變化正在重塑市場競爭格局，迫使現有企業和新參與企業重新審視其產品策略和技術資料。

同時，監管趨勢和品質期望不斷提高，促使製造商採用更高的雜質譜分析和分析證書標準。因此，材料規格和供應商審核已成為籌資策略的關鍵組成部分。與這種對品質的重視相一致，製造技術的進步，特別是生物合成和結晶/製粒技術的進步，使製造商能夠根據顆粒特性、溶解度和感官特性進行差異化生產，從而拓展應用範圍。

這種轉變也凸顯了跨部門協作的重要性。產品開發人員必須與監管事務和採購部門協調，才能將技術優勢轉化為符合法規的聲明和可靠的供應。最終，這將造就一個重視透明度、技術嚴謹性和快速將新興科學轉化為可擴展配方能力的產業。

2025年美國關稅對菸鹼醯胺供應鏈、籌資策略及生產路線選擇的影響

美國將於2025年實施關稅，這迫使菸鹼醯胺價值鏈上的相關人員重新評估其採購管道和成本結構。貿易政策的變化增加了對多元化供應商組合和緊急時應對計畫的需求，尤其是對於那些先前依賴集中式原料供應的公司。因此，採購團隊正在審查契約，並考慮近岸外包和戰略庫存緩衝，以減輕運輸和關稅相關中斷的影響。

這些關稅不僅影響直接成本，也影響供應商的長期選擇和合約條款。買家不再只專注於標價，而是越來越重視包含物流、物流波動和庫存持有成本在內的總到岸成本分析。這種轉變促使一些製造商尋求垂直整合策略，或簽訂多原產地協議，以便根據關稅制度和物流限制獲得更大的靈活性。

同時，關稅環境正在加速企業對替代生產路線的興趣。各公司正在評估生物合成路線、植物來源製程以及本地投資的技術和商業性可行性，以降低跨境摩擦帶來的風險。從策略角度來看，那些積極重塑供應鏈並調整商業模式的公司，將更有利於在日益加強貿易保護主義的環境下保護淨利率並確保供應的連續性。

全面的細分分析能夠準確區分應用、格式、通路、最終用戶和材料屬性，從而指南技術和商業性優先排序。

有效的細分分析能夠揭示價值和風險在應用、劑型、通路、最終用戶和材料特性等方面的集中程度。基於應用，市場細分涵蓋動物飼料、化妝品、營養保健品、食品飲料和藥品。動物飼料進一步細分為水產飼料、牛飼料、家禽飼料和豬飼料。化妝品進一步分為彩妝品、護髮和護膚，其中護膚又細分為抗衰老、提亮和保濕等子類別。營養保健品按膠囊、液體、粉末和片劑區分；食品飲料按烘焙食品、糖果甜點和乳製品區分；藥品按非處方藥和處方藥區分。這種多層次的視角突顯了技術規範和監管要求差異最為顯著之處。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 由於菸鹼醯胺具有提亮膚色和修復皮膚屏障的功效，因此在美容護膚程序中，含有菸鹼醯胺的多功能護膚配方的需求正在增加。
  • 清潔美容運動的興起，強調使用來自永續農業來源的天然成分，並減少化學物質的使用。
  • 隨著消費者意識從臉部護膚擴展到其他領域，菸鹼醯胺正擴大被應用於身體保養和頭皮護理。
  • 皮膚科醫生推薦的處方箋級菸鹼醯胺產品已大量湧現，用於治療色素沉澱和痤瘡。
  • 該公司正在拓展其個人化美容平台，該平台可根據個人皮膚微生物組分析結果提供客製化的菸鹼醯胺濃度。
  • 微膠囊化技術的創新可提高化妝品乳液和精華液的穩定性和控制釋放
  • 推出聯名產品，將菸鹼醯胺與胜肽和神經醯胺結合，以發揮協同抗衰老功效
  • 隨著亞太地區消費者偏好的轉變，韓妝的影響和消費者教育宣傳活動推動了菸鹼醯胺在亞太地區的使用。
  • 電子商務的成長帶動了直接面對消費者的菸鹼醯胺品牌數量激增，包括超值裝產品和與網紅合作的產品。
  • 監管審查和不斷變化的品質標準影響藥用級菸鹼醯胺原料的供應鏈透明度。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 菸鹼醯胺市場依應用領域分類

  • 動物飼料
    • 水產飼料
    • 牛飼料
    • 家禽飼料
    • 豬飼料
  • 化妝品
    • 彩妝
    • 護髮
    • 護膚
      • 抗衰老
      • 提亮
      • 保濕
  • 營養補充品
    • 膠囊
    • 液體
    • 粉末
    • 藥片
  • 食品/飲料
    • 麵包店
    • 糖果甜點
    • 乳製品
  • 製藥
    • 非處方藥
    • 處方藥

9. 菸鹼醯胺市場按劑型分類

  • 膠囊
  • 液體
  • 粉末
  • 藥片

第10章 菸鹼醯胺市場（依分銷通路分類）

  • 電子商務
    • 公司網站
    • 第三方平台
  • 線下零售
    • 藥房和藥品商店
    • 專賣店
    • 超級市場和大賣場

第11章 菸鹼醯胺市場（依最終用戶分類）

  • 飼料生產商
  • 食品和飲料製造商
  • 個人護理用品製造商
  • 製藥商

第12章 菸鹼醯胺市場及其特性

  • 自然的
    • 植物來源
    • 酵母衍生的
  • 合成
    • 生物合成
    • 石油化工衍生性商品

13. 各地區菸鹼醯胺市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 菸鹼醯胺市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國菸鹼醯胺市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Koninklijke DSM NV
    • Lonza Group AG
    • BASF SE
    • Merck KGaA
    • Roquette Freres
    • Zhejiang Medicine Co., Ltd.
    • Hefei TNJ Chemical Co., Ltd.
    • Wuhan Grand Harvest Biotech Co., Ltd.
    • Shandong Pharmaceutical Group Co., Ltd.
    • Shanghai Lixin Biochemical Technology Co., Ltd.
Product Code: MRR-9E01E2DC4AC3

The Niacinamide Market is projected to grow by USD 1,090.26 million at a CAGR of 4.86% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 745.60 million
Estimated Year [2025] USD 782.66 million
Forecast Year [2032] USD 1,090.26 million
CAGR (%) 4.86%

A concise strategic orientation to niacinamide that frames its multidisciplinary relevance across nutrition, cosmetics, feed, and therapeutic product ecosystems

Niacinamide has evolved from a narrowly focused ingredient to a multifaceted active that intersects nutrition, animal health, cosmetics, and pharmaceuticals. As an essential form of vitamin B3, its functional versatility-ranging from skin barrier support to metabolic roles in feed and therapeutic applications-has expanded interest among formulators, manufacturers, and procurement teams. This introduction frames the ingredient through the lens of contemporary demand drivers and technical considerations that matter to decision-makers.

Industry stakeholders are now navigating a more complex landscape where consumer claims, regulatory scrutiny, supply chain resilience, and raw material provenance exert simultaneous influence on product strategy. Consequently, product managers and R&D leaders must reconcile shelf-life and formulation stability with sensory and efficacy expectations. At the same time, procurement and supply chain professionals must address feedstock origin, synthesis pathways, and potential trade frictions that affect availability and cost basis.

This section sets the stage for the deeper analysis that follows by highlighting how niacinamide's cross-sector relevance necessitates integrated planning. It underscores the importance of placing scientific evidence, regulatory alignment, and sourcing strategy at the center of commercial planning to preserve brand trust and meet evolving market requirements.

How evolving consumer, regulatory, and manufacturing priorities are reshaping niacinamide sourcing, formulation, and product differentiation strategies

The niacinamide landscape is experiencing transformative shifts driven by consumer expectations, formulation innovation, and supply chain reconfiguration. Rising demand for clean-label and multifunctional actives is prompting brands to prioritize ingredient transparency and traceability, while R&D teams invest in delivery systems that optimize bioavailability and cosmetic compatibility. Those changes are reshaping the competitive set and forcing incumbents and new entrants alike to rethink product narratives and technical dossiers.

Simultaneously, regulatory trends and quality expectations have tightened, encouraging manufacturers to adopt higher standards for impurity profiling and certificates of analysis. As a result, material specifications and vendor audits have gained prominence in sourcing strategies. Parallel to these quality-focused changes, advances in manufacturing-particularly bio-synthetic methods and improved crystallization or granulation techniques-are enabling producers to differentiate on particle properties, solubility, and sensory profile, thus broadening application potential.

These shifts also amplify the importance of cross-functional collaboration; product developers must coordinate with regulatory affairs and procurement to translate technical advantages into compliant claims and reliable supply. The net effect is an industry that rewards transparency, technical rigor, and the ability to rapidly translate emerging science into scalable formulations.

Implications of the 2025 United States tariff regime on niacinamide supply chains, procurement strategies, and manufacturing pathway choices

The introduction of tariff measures in the United States in 2025 has compelled stakeholders across the niacinamide value chain to reassess sourcing routes and cost structures. Trade policy changes have heightened the need for diversified supplier portfolios and contingency planning, especially for companies that previously relied on concentrated sources of raw materials. Procurement teams are therefore recalibrating contracts and exploring nearshoring or strategic inventory buffers to mitigate transit and duty-related disruptions.

Beyond immediate cost implications, these tariffs are influencing long-term supplier selection and contractual terms. Buyers are placing greater emphasis on total landed cost analysis, which incorporates duties, logistics variability, and inventory holding costs, rather than focusing solely on headline unit prices. This shift is prompting some manufacturers to pursue vertically integrated strategies or to secure multi-origin contracts that can be flexed according to duty regimes and logistical constraints.

In parallel, the tariff environment is accelerating interest in alternative manufacturing pathways. Firms are evaluating the technical and commercial viability of bio-synthetic routes, vegetable-derived processes, and localized investment to reduce exposure to cross-border friction. From a strategic perspective, companies that proactively redesign supply chains and adjust commercial models will be better positioned to preserve margin and ensure continuity of supply in a more protectionist trade climate.

Comprehensive segmentation analysis revealing precise application, form, channel, end user, and material nature distinctions that guide technical and commercial prioritization

Effective segmentation analysis illuminates where value and risk concentrate across applications, forms, channels, end users, and material nature. Based on Application, the market is studied across Animal Feed, Cosmetics, Dietary Supplements, Food And Beverage, and Pharmaceuticals, with Animal Feed further subdivided into Aquaculture Feed, Cattle Feed, Poultry Feed, and Swine Feed; Cosmetics is elaborated into Color Cosmetics, Hair Care, and Skin Care, and Skin Care is explored through Anti-Aging, Brightening, and Moisturizing subsegments. Dietary Supplements are analyzed by Capsules, Liquid, Powder, and Tablets, while Food And Beverage considers Bakery, Confectionery, and Dairy, and Pharmaceuticals differentiates Over-The-Counter Drugs from Prescription Drugs. This multi-layered view clarifies where technical specification and regulatory expectation vary most dramatically.

Based on Form, the market is studied across Capsules, Liquid, Powder, and Tablets, a segmentation that shapes considerations such as dissolution behavior, storage stability, and compatibility with co-formulants. Based on Distribution Channel, the market is studied across E-Commerce and Offline Retail, with E-Commerce further delineated into Company Website and Third-Party Platforms and Offline Retail elaborated as Pharmacies And Drug Stores, Specialty Stores, and Supermarkets And Hypermarkets; channel choice influences packaging, labeling, and promotional strategies along with regulatory compliance in different territories. Based on End User, the market is studied across Feed Manufacturers, Food And Beverage Manufacturers, Personal Care Manufacturers, and Pharmaceutical Manufacturers, each bringing distinct technical specifications and procurement protocols.

Based on Nature, the market is studied across Natural and Synthetic, with Natural further differentiated into Vegetable-Derived and Yeast-Derived sources and Synthetic subdivided into Bio-Synthetic and Petrochemical-Sourced pathways. Understanding these distinctions enables stakeholders to tailor purity requirements, sustainability messaging, and supply continuity plans. Together, these segmentation layers provide a roadmap for prioritizing product development, regulatory submissions, and commercial positioning based on where technical attributes and buyer expectations align most tightly.

Regional dynamics and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence sourcing, compliance, and commercial strategy

Regional dynamics materially shape demand patterns, regulatory contexts, and supply chain pathways for niacinamide. In the Americas, commercial activity is driven by a blend of consumer-facing personal care innovation and a robust supplement and pharmaceutical market that emphasizes clinical substantiation and label transparency. Supply considerations in this region also favor resilience and regulatory alignment, prompting manufacturers to adopt stringent quality controls and to emphasize traceability from feedstock to finished good.

Europe, Middle East & Africa presents a heterogeneous regulatory and commercial landscape where ingredient provenance, sustainability credentials, and safety dossiers carry significant weight. High regulatory thresholds in several European markets require detailed impurity profiles and compliance with advanced cosmetic and pharmaceutical directives, while growing markets in the Middle East and Africa prioritize affordability and scalable supply, creating diverse opportunities for different value propositions.

Asia-Pacific exhibits rapid innovation and production capacity expansion, underpinned by strong manufacturing ecosystems and a fast-moving consumer base that often adopts new formulations quickly. This region combines advanced technical capabilities with growing domestic demand across personal care, dietary supplements, and feed applications. Across these geographies, firms must tailor regulatory strategies, supply chain architectures, and marketing narratives to local expectations while maintaining global consistency in quality and safety.

Competitive dynamics showing how technical differentiation, regulatory capability, and supply reliability define leadership among niacinamide suppliers

The competitive landscape is characterized by a mix of ingredient specialists, chemical producers, and vertically integrated suppliers, each pursuing different strategies to capture value. Leading producers differentiate through technical rigor-offering detailed impurity profiles, customized particle engineering, and application-specific grades-while others emphasize scale and cost competitiveness. Strategic partnerships between ingredient suppliers and brand formulators are becoming more common, allowing for co-development of stabilized systems and proprietary formulations that deliver enhanced performance for targeted applications.

Innovation is also driving consolidated service offerings, where companies combine regulatory support, dossier preparation, and supply continuity assurances to address customer concerns holistically. In addition, several firms are investing in sustainability claims, traceability solutions, and certifications that validate source attribution, particularly for products positioned as natural or vegetable-derived. These investments are not only marketing differentiators but also risk mitigation tools as buyers increasingly demand chain-of-custody information.

Smaller, nimble players are carving niches by targeting specialized application needs-such as ultra-pure grades for pharmaceuticals or sensory-optimized grades for premium cosmetics-while larger firms leverage global footprints to offer multi-origin supply and scale benefits. Collectively, these dynamics create a market where technical capability, regulatory competence, and supply reliability determine competitive positioning.

Actionable strategic priorities for stakeholders to strengthen sourcing resilience, accelerate formulation innovation, and enhance regulatory and sustainability positioning

Industry leaders should adopt a proactive, integrated approach to maintain resilience and capture growth opportunities in the niacinamide market. First, align sourcing strategy with technical and regulatory requirements by integrating total landed cost analysis, supplier audits, and multi-origin contracts into procurement playbooks. This will minimize exposure to trade disruptions while preserving formulation performance expectations. Second, invest in application-specific R&D to create differentiated grades that address stability, solubility, and sensory objectives in cosmetics, formulations for dietary supplements, and targeted feed applications.

Third, strengthen regulatory and quality assurance capabilities by standardizing impurity profiling, expanding dossier completeness, and adopting transparent labeling practices that enhance customer confidence. Fourth, prioritize sustainability and traceability initiatives-such as validated source documentation for vegetable-derived or yeast-derived inputs and credible carbon or stewardship claims-to support premium positioning and meet evolving customer expectations. Fifth, explore strategic partnerships and co-development agreements with brand owners to accelerate route-to-market for novel formulations and to ensure alignment between technical claims and real-world performance.

Finally, implement scenario-based planning that accounts for tariff volatility, logistics interruptions, and raw material availability. By combining technical differentiation with operational agility and rigorous compliance, companies can simultaneously mitigate risk and unlock new opportunities across multiple application segments.

A transparent mixed-methods research approach blending primary practitioner interviews, technical literature review, and triangulated data analysis to ensure robust conclusions

The research underpinning this analysis combines qualitative and quantitative approaches designed to ensure comprehensive coverage of technical, commercial, and regulatory dimensions. Primary inputs included structured interviews with industry practitioners across formulation, procurement, regulatory affairs, and supply chain roles, providing first-hand perspectives on technical specifications, sourcing strategies, and market needs. These interviews were complemented by targeted engagement with manufacturers and end users across personal care, dietary supplements, pharmaceuticals, food and beverage, and feed sectors to capture application-specific insights.

Secondary inputs included peer-reviewed scientific literature, regulatory documentation, and technical white papers that informed discussions on impurity profiling, manufacturing pathways, and formulation best practices. Trade data and customs documentation were examined to identify shifts in flows and to contextualize discussions about duty impacts and logistic constraints. Cross-validation techniques were employed to reconcile differing viewpoints and to triangulate the most robust findings.

Analysis methods prioritized transparency and reproducibility. Technical assertions were corroborated with multiple independent sources, and methodological assumptions were documented to support interpretability by technical and commercial audiences. Wherever applicable, sensitivity assessments were conducted to illustrate how changes in trade policy, feedstock origin, or manufacturing pathways could influence strategic decision-making.

Synthesis of strategic imperatives showing how technical rigor, procurement discipline, and regulatory readiness together determine commercial success in niacinamide

Niacinamide occupies a strategic intersection of nutrition, health, and personal care where technical performance, regulatory compliance, and supply chain resilience converge. Throughout this analysis, recurring themes emerged: the premium placed on material provenance and impurity control, the commercial value of application-specific formulations, and the operational need to manage trade and logistical volatility. These themes point to a market that rewards companies capable of integrating scientific rigor with pragmatic supply strategies.

Looking across applications and geographies, it becomes clear that success will favor organizations that can deliver consistent quality at a competitive total cost while responding nimbly to regulatory variation and evolving consumer expectations. Those that invest in differentiated product grades, transparent sourcing narratives, and targeted partnerships will be better positioned to meet the nuanced demands of cosmetics formulators, supplement manufacturers, feed producers, and pharmaceutical clients.

In summary, the evolutionary trajectory of the niacinamide market underscores the importance of aligning R&D priorities with procurement discipline and regulatory readiness. By doing so, stakeholders can turn technical strengths into commercial advantage and build resilient operations that accommodate both short-term disruptions and long-term shifts in demand.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for multifunctional skincare formulations with niacinamide due to its brightening and barrier repair properties in beauty routines
  • 5.2. Growth of clean beauty movements emphasizing naturally derived niacinamide from sustainable agricultural sources and reduced chemical footprint
  • 5.3. Increasing integration of niacinamide in body care and scalp treatments as broader consumer awareness expands beyond facial skincare
  • 5.4. Surge in dermatologist-backed prescription-strength niacinamide products for targeted treatment of hyperpigmentation and acne
  • 5.5. Expansion of personalized beauty platforms offering customized niacinamide concentrations based on individual skin microbiome analysis
  • 5.6. Innovations in microencapsulation technology enhancing niacinamide stability and controlled release in cosmetic emulsions and serums
  • 5.7. Collaborative product launches featuring niacinamide paired with peptides and ceramides for synergistic anti-ageing benefits
  • 5.8. Regional preference shifts boosting niacinamide usage in Asia-Pacific due to K-beauty influences and consumer education campaigns
  • 5.9. E-commerce growth driving proliferation of direct to consumer niacinamide brands with value pack formats and influencer collaborations
  • 5.10. Regulatory scrutiny and evolving quality standards impacting supply chain transparency for pharmaceutical grade niacinamide ingredients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Niacinamide Market, by Application

  • 8.1. Animal Feed
    • 8.1.1. Aquaculture Feed
    • 8.1.2. Cattle Feed
    • 8.1.3. Poultry Feed
    • 8.1.4. Swine Feed
  • 8.2. Cosmetics
    • 8.2.1. Color Cosmetics
    • 8.2.2. Hair Care
    • 8.2.3. Skin Care
      • 8.2.3.1. Anti-Aging
      • 8.2.3.2. Brightening
      • 8.2.3.3. Moisturizing
  • 8.3. Dietary Supplements
    • 8.3.1. Capsules
    • 8.3.2. Liquid
    • 8.3.3. Powder
    • 8.3.4. Tablets
  • 8.4. Food And Beverage
    • 8.4.1. Bakery
    • 8.4.2. Confectionery
    • 8.4.3. Dairy
  • 8.5. Pharmaceuticals
    • 8.5.1. Over-The-Counter Drugs
    • 8.5.2. Prescription Drugs

9. Niacinamide Market, by Form

  • 9.1. Capsules
  • 9.2. Liquid
  • 9.3. Powder
  • 9.4. Tablets

10. Niacinamide Market, by Distribution Channel

  • 10.1. E-Commerce
    • 10.1.1. Company Website
    • 10.1.2. Third-Party Platforms
  • 10.2. Offline Retail
    • 10.2.1. Pharmacies And Drug Stores
    • 10.2.2. Specialty Stores
    • 10.2.3. Supermarkets And Hypermarkets

11. Niacinamide Market, by End User

  • 11.1. Feed Manufacturers
  • 11.2. Food And Beverage Manufacturers
  • 11.3. Personal Care Manufacturers
  • 11.4. Pharmaceutical Manufacturers

12. Niacinamide Market, by Nature

  • 12.1. Natural
    • 12.1.1. Vegetable-Derived
    • 12.1.2. Yeast-Derived
  • 12.2. Synthetic
    • 12.2.1. Bio-Synthetic
    • 12.2.2. Petrochemical-Sourced

13. Niacinamide Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Niacinamide Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Niacinamide Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Koninklijke DSM N.V.
    • 16.3.2. Lonza Group AG
    • 16.3.3. BASF SE
    • 16.3.4. Merck KGaA
    • 16.3.5. Roquette Freres
    • 16.3.6. Zhejiang Medicine Co., Ltd.
    • 16.3.7. Hefei TNJ Chemical Co., Ltd.
    • 16.3.8. Wuhan Grand Harvest Biotech Co., Ltd.
    • 16.3.9. Shandong Pharmaceutical Group Co., Ltd.
    • 16.3.10. Shanghai Lixin Biochemical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NIACINAMIDE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NIACINAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY AQUACULTURE FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NIACINAMIDE MARKET SIZE, BY CATTLE FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NIACINAMIDE MARKET SIZE, BY POULTRY FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NIACINAMIDE MARKET SIZE, BY SWINE FEED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NIACINAMIDE MARKET SIZE, BY COLOR COSMETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NIACINAMIDE MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NIACINAMIDE MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NIACINAMIDE MARKET SIZE, BY ANTI-AGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NIACINAMIDE MARKET SIZE, BY BRIGHTENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NIACINAMIDE MARKET SIZE, BY MOISTURIZING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NIACINAMIDE MARKET SIZE, BY BAKERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NIACINAMIDE MARKET SIZE, BY CONFECTIONERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NIACINAMIDE MARKET SIZE, BY DAIRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NIACINAMIDE MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NIACINAMIDE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NIACINAMIDE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NIACINAMIDE MARKET SIZE, BY TABLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NIACINAMIDE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NIACINAMIDE MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NIACINAMIDE MARKET SIZE, BY THIRD-PARTY PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACIES AND DRUG STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NIACINAMIDE MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NIACINAMIDE MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NIACINAMIDE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL NIACINAMIDE MARKET SIZE, BY PERSONAL CARE MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURE, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL NIACINAMIDE MARKET SIZE, BY VEGETABLE-DERIVED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL NIACINAMIDE MARKET SIZE, BY YEAST-DERIVED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL NIACINAMIDE MARKET SIZE, BY BIO-SYNTHETIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL NIACINAMIDE MARKET SIZE, BY PETROCHEMICAL-SOURCED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS NIACINAMIDE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS NIACINAMIDE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS NIACINAMIDE MARKET SIZE, BY COSMETICS, 2025-2032 (USD MILLION)
  • TABLE 315. AMERICAS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2024 (USD MILLION)
  • TABLE 316. AMERICAS NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2024 (USD MILLION)
  • TABLE 320. AMERICAS NIACINAMIDE MARKET SIZE, BY FOOD AND BEVERAGE, 2025-2032 (USD MILLION)
  • TABLE 321. AMERICAS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 322. AMERICAS NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 323. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 324. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 325. AMERICAS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 326. AMERICAS NIACINAMIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 327. AMERICAS NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
  • TABLE 328. AMERICAS NIACINAMIDE MARKET SIZE, BY E-COMMERCE, 2025-2032 (USD MILLION)
  • TABLE 329. AMERICAS NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
  • TABLE 330. AMERICAS NIACINAMIDE MARKET SIZE, BY OFFLINE RETAIL, 2025-2032 (USD MILLION)
  • TABLE 331. AMERICAS NIACINAMIDE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. AMERICAS NIACINAMIDE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURE, 2018-2024 (USD MILLION)
  • TABLE 334. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURE, 2025-2032 (USD MILLION)
  • TABLE 335. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
  • TABLE 336. AMERICAS NIACINAMIDE MARKET SIZE, BY NATURAL, 2025-2032 (USD MILLION)
  • TABLE 337. AMERICAS NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2018-2024 (USD MILLION)
  • TABLE 338. AMERICAS NIACINAMIDE MARKET SIZE, BY SYNTHETIC, 2025-2032 (USD MILLION)
  • TABLE 339. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 340. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 341. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
  • TABLE 344. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY ANIMAL FEED, 2025-2032 (USD MILLION)
  • TABLE 345. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2018-2024 (USD MILLION)
  • TABLE 346. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY COSMETICS, 2025-2032 (USD MILLION)
  • TABLE 347. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2018-2024 (USD MILLION)
  • TABLE 348. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY SKIN CARE, 2025-2032 (USD MILLION)
  • TABLE 349. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
  • TABLE 350. NORTH AMERICA NIACINAMIDE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2032 (USD MILLION)
  • TABLE 351. NORTH AMERICA NIACINAMIDE MARKET SI